NASDAQ:CYTK
Cytokinetics Stock Signals
Latest Data & Signals Issued
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | -1.575 | 15 days ( 10.86 % ) | |
| Last Price | $34.98 | 1.30 % | |
| High/ Low | $33.98 - $35.60 | 1.60% | |
| Chg 7 Days | -3.32 % | $36.18 $34.98 | |
| Chg 30 Days | -18.29 % | $42.81 $34.98 | |
| Chg 12 mos | -4.84 % | $36.76 $34.98 | |
| Trend - 3 mos | -17.30 % | Width: 26.74 % | |
| Trend - 12 mos | -0.426 % | Width: 52.35 % | |
| Pred. range - 3 mos | $27.35 - $34.66 | -21.82 % - -0.91 % | |
| Pred. range - 12 mos | $35.55 - $54.16 | 1.63 % - 54.83 % | |
| Short mv avg 3 mos | Buy | 2023-03-27 - 2 days | |
| Long mv avg 3 mos | Buy | 2023-02-27 - 22 days | |
| Short/Long mv avg 3 mos | Sell | 2023-02-27 - 22 days | |
| Short mv avg 12 mos | Buy | 2023-02-27 - 22 days | |
| Long mv avg 12 mos | Sell | 2023-03-01 - 20 days | |
| Short/Long mv avg 12 mos | Sell | 2023-03-03 - 18 days | |
| Pivot Short | Sell | 2023-03-24 - 3 days | |
| Bollinger | Buy | 2023-03-10 - 13 days | |
| MACD | Buy | No Dates Stored For This Signal |
CYTK splits
| Date | Ratio | Status |
|---|---|---|
| 2013-06-25 | 1:6 |
About Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
